Alexei Goraltchouk
Chief Operating Officer at Remedium Bio, Inc.
Profile
Alexei Goraltchouk is currently the Chief Operating Officer & Director at Remedium Bio, Inc. Previously, he worked as the Senior VP-Operations & Project Management at Anika Therapeutics, Inc. from 2018 to 2021 and as the Vice President-Operations at Avedro, Inc. He holds a graduate degree and an MBA from Indiana University and an undergraduate and graduate degree from the University of Toronto.
Alexei Goraltchouk active positions
Companies | Position | Start |
---|---|---|
Remedium Bio, Inc.
Remedium Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Remedium Bio, Inc. is a biotechnology company that focuses on the development of curative treatments. The company is based in Needham, MA. The CEO of the company is Francesco J. Luppino. | Chief Operating Officer | - |
Former positions of Alexei Goraltchouk
Companies | Position | End |
---|---|---|
ANIKA THERAPEUTICS, INC. | Chief Operating Officer | 31/12/2020 |
AVEDRO, INC. | Chief Operating Officer | - |
Training of Alexei Goraltchouk
Indiana University | Graduate Degree |
University of Toronto | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
ANIKA THERAPEUTICS, INC. | Health Technology |
Private companies | 2 |
---|---|
Avedro, Inc.
Avedro, Inc. Medical SpecialtiesHealth Technology Avedro, Inc. develops ophthalmic medical devices and pharmaceutical products. The firm’s products include KXL System, Mosaic system, IROC system and Riboflavin family. Its procedure includes Lasic Xtra, accelerated cross-linking and photorefractive intrastromal cross-linking. The company was founded by David F. Muller and B. Stuart Trembly on November 6, 2002 and is headquartered in Waltham, MA. | Health Technology |
Remedium Bio, Inc.
Remedium Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Remedium Bio, Inc. is a biotechnology company that focuses on the development of curative treatments. The company is based in Needham, MA. The CEO of the company is Francesco J. Luppino. | Commercial Services |
- Stock Market
- Insiders
- Alexei Goraltchouk